$3.49
-0.17-4.64%
At close: -
$3.51
0.020.57%
After Hours: Dec 20, 7:53 PM EDT
Comments
Loading...
Geron (NASDAQ:GERN) Stock Quotes, Forecast and News Summary
Geron Stock (NASDAQ: GERN) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Geron (GERN) stock?
You can purchase shares of Geron (NASDAQ:GERN) through any online brokerage.
Who are Geron (GERN) competitors?
Other companies in Geron’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Twist Bioscience (NASDAQ:TWST), Centessa Pharmaceuticals (NASDAQ:CNTA), SpringWorks Therapeutics (NASDAQ:SWTX) and Mesoblast (NASDAQ:MESO).
What is the forecast, or price target, for Geron (GERN) stock?
Geron has a consensus price target of $7.04.
What is the current price for Geron (GERN)?
The stock price for Geron (NASDAQ: GERN) is $3.51 last updated December 20, 2024 at 7:53 PM EST.
Does Geron (GERN) pay a dividend?
There are no upcoming dividends for Geron.
When is Geron (NASDAQ:GERN) reporting earnings?
Geron’s Q4 earnings are confirmed for Wednesday, February 26, 2025.
Is Geron (GERN) going to split?
There is no upcoming split for Geron.
What sector and industry does Geron (GERN) operate in?
Geron is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.